Add BrightSurf on Google Email

Science News for January 15, 2003


Presence of certain tumor markers for melanoma could signal best results for vaccine

A recent study by the American Association for Cancer Research found that patients with advanced melanoma expressing higher levels of melanoma-associated antigens (MAAs) experienced significantly improved survival outcomes. The study suggests that these tumors may be more responsive to immunotherapy, such as vaccines against melanoma.

SourceAmerican Association for Cancer Research·JournalCancer Research·DateJan 15, 2003